<p>Artisan Partners Limited Partnership 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第二季度减少了对史赛克公司（NYSE:SYK - 免费报告）股票的持有，降幅为 9.7%。该基金在此期间出售了 1,134 股后，持有该医疗科技公司 10,530 股股票。Artisan Partners Limited Partnership 在史赛克的持股在最近一个季度末价值为 4,166,000 美元。</p>
<ul>
<li>注意死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
<p>其他几家对冲基金也最近调整了对该股票的持有。美国联合服务汽车协会在第一季度新建了对史赛克的持仓，价值为 2,857,000 美元。Hendley &amp; Co. Inc. 在第二季度将其在史赛克的持仓提高了 60.3%。Hendley &amp; Co. Inc. 现在持有 14,018 股该医疗科技公司的股票，价值为 5,546,000 美元，此前在上个季度又购买了 5,274 股。AXS Investments LLC 在第一季度增加了对史赛克的持仓，增幅为 13.7%。AXS Investments LLC 现在持有 8,827 股该医疗科技公司的股票，价值为 3,286,000 美元，此前在此期间又收购了 1,062 股。Two Point Capital Management Inc. 在第二季度购买了价值约为 7,281,000 美元的史赛克新股份。最后，King Luther Capital Management Corp 在第二季度将其在史赛克的股份提高了 7.9%。King Luther Capital Management Corp 现在持有 447,479 股该医疗科技公司的股票，价值为 177,036,000 美元，此前在上个季度又购买了 32,682 股。机构投资者和对冲基金持有该公司 77.09% 的股票。</p>
<h2>史赛克股票上涨 2.2%</h2>
<p>SYK 股票在周五开盘价为 368.35 美元。该公司的债务与股本比率为 0.70，流动比率为 1.78，速动比率为 1.06。该股票的市值为 1,408.7 亿美元，市盈率为 48.79，PEG 比率为 2.66，贝塔值为 0.94。史赛克公司的 52 周最低价为 329.16 美元，52 周最高价为 406.19 美元。该公司的 50 日移动平均价格为 369.38 美元，200 日移动平均价格为 380.68 美元。</p>
<ul>
<li>如果你只能持有 3 项投资一生，请考虑这些</li>
</ul>
<p>史赛克（NYSE:SYK - 获取免费报告）最近在 10 月 30 日（星期四）发布了季度财报。该医疗科技公司报告季度每股收益为 3.19 美元，超出分析师一致预期的 3.13 美元，超出幅度为 0.06 美元。史赛克的股本回报率为 23.94%，净利润率为 12.25%。该公司季度收入为 60.6 亿美元，而分析师预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。史赛克的收入同比增长 10.2%。史赛克已将其 2025 财年的指导目标设定为每股收益 13.500-13.600 美元。平均而言，股票分析师预计史赛克公司今年将发布每股收益 13.47 美元。</p>
<h2>华尔街分析师观点</h2>
<p>一些券商最近对 SYK 发表了看法。富国银行将史赛克的目标价从 452.00 美元上调至 456.00 美元，并在 11 月 14 日的报告中给予该公司 “增持” 评级。桑福德·C·伯恩斯坦在 11 月 3 日的研究报告中重申了对史赛克股票的 “跑赢大盘” 评级。Truist Financial 在 11 月 14 日的研究报告中将史赛克的目标价从 392.00 美元上调至 400.00 美元，并给予该公司 “持有” 评级。巴克莱在 10 月 22 日的研究报告中将史赛克的目标价从 443.00 美元上调至 453.00 美元，并给予该公司 “增持” 评级。最后，罗斯柴尔德与红烧开始覆盖史赛克股票，并在 9 月 18 日的研究报告中设定了 “中性” 评级和 420.00 美元的目标价。十三位研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 434.37 美元。</p>
<ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
<p><strong>获取我们对史赛克的最新分析</strong></p>
<h2>内部买卖</h2>
<p>在其他史赛克新闻中，内部人士 Viju Menon 在 8 月 25 日（星期一）出售了 500 股公司的股票。该股票以平均价格 390.61 美元出售，总价值为 195,305.00 美元。出售后，内部人士持有该公司 12,511 股，价值约为 4,886,921.71 美元。此次交易使其持仓减少了 3.84%。该交易在 SEC 的文件中披露，相关信息可通过此链接访问。此外，首席财务官 Preston Wendell Wells 在 11 月 20 日（星期四）出售了 165 股公司的股票。这些股票以平均价格 365.88 美元出售，总交易额为 60,370.20 美元。出售后，首席财务官直接持有该公司 6,694 股，价值为 2,449,200.72 美元。此次交易使其持仓减少了 2.41%。该出售的 SEC 文件提供了更多信息。在过去三个月中，内部人士已出售 522,618 股公司股票，价值为 185,577,237 美元。公司内部人士持有公司 5.90% 的股票。</p>
<h2>史赛克公司简介</h2>
<p>（免费报告）</p>
<p>史赛克公司是一家医疗科技公司。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换手术的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比史赛克更好</li>
<li>如何在 5 个简单步骤中做空股票</li>
<li>一项宏伟的人工智能投资？斯坦利·德鲁肯米勒最新的科技动态</li>
<li>最活跃的股票：美元交易量与股票交易量</li>
<li>12 位分析师刚刚上调了 CrowdStrike 的目标——他们预见了什么</li>
<li>使用 MarketBeat 股票拆分计算器</li>
<li>帕洛阿尔托网络的股票刚刚回调——这是一个理想的买入区吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
<p>在考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Artisan合伙资产管理

史赛克

<p>Artisan Partners Limited Partnership 在第二季度减少了对史赛克公司的持股 9.7%，目前持有 10,530 股，价值 417 万美元。其他对冲基金也调整了他们的持仓。史赛克的股票开盘价为 368.35 美元，市值为 1408.7 亿美元。最近的财报显示每股收益为 3.19 美元，超出预期。分析师给予 “适度买入” 的评级，平均目标价为 434.37 美元</p>

<p>Artisan Partners Limited Partnership decreased its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 9.7% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 10,530 shares of the medical technology company's stock after selling 1,134 shares during the period. Artisan Partners Limited Partnership's holdings in Stryker were worth $4,166,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Artisan Partners Limited Partnership 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第二季度减少了对史赛克公司（NYSE:SYK - 免费报告）股票的持有，降幅为 9.7%。该基金在此期间出售了 1,134 股后，持有该医疗科技公司 10,530 股股票。Artisan Partners Limited Partnership 在史赛克的持股在最近一个季度末价值为 4,166,000 美元。</p>
</div><ul>
<li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li>
</ul>
<div class="lb-trans"><ul>
<li>注意死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
</div><p>Several other hedge funds have also recently modified their holdings of the stock. United Services Automobile Association acquired a new position in Stryker in the first quarter valued at $2,857,000. Hendley &amp; Co. Inc. lifted its position in shares of Stryker by 60.3% in the 2nd quarter. Hendley &amp; Co. Inc. now owns 14,018 shares of the medical technology company's stock worth $5,546,000 after buying an additional 5,274 shares during the last quarter. AXS Investments LLC increased its holdings in shares of Stryker by 13.7% in the 1st quarter. AXS Investments LLC now owns 8,827 shares of the medical technology company's stock worth $3,286,000 after acquiring an additional 1,062 shares during the period. Two Point Capital Management Inc. bought a new stake in shares of Stryker during the second quarter valued at about $7,281,000. Finally, King Luther Capital Management Corp raised its stake in shares of Stryker by 7.9% in the 2nd quarter. King Luther Capital Management Corp now owns 447,479 shares of the medical technology company's stock worth $177,036,000 after buying an additional 32,682 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金也最近调整了对该股票的持有。美国联合服务汽车协会在第一季度新建了对史赛克的持仓，价值为 2,857,000 美元。Hendley &amp; Co. Inc. 在第二季度将其在史赛克的持仓提高了 60.3%。Hendley &amp; Co. Inc. 现在持有 14,018 股该医疗科技公司的股票，价值为 5,546,000 美元，此前在上个季度又购买了 5,274 股。AXS Investments LLC 在第一季度增加了对史赛克的持仓，增幅为 13.7%。AXS Investments LLC 现在持有 8,827 股该医疗科技公司的股票，价值为 3,286,000 美元，此前在此期间又收购了 1,062 股。Two Point Capital Management Inc. 在第二季度购买了价值约为 7,281,000 美元的史赛克新股份。最后，King Luther Capital Management Corp 在第二季度将其在史赛克的股份提高了 7.9%。King Luther Capital Management Corp 现在持有 447,479 股该医疗科技公司的股票，价值为 177,036,000 美元，此前在上个季度又购买了 32,682 股。机构投资者和对冲基金持有该公司 77.09% 的股票。</p>
</div><h2>Stryker Stock Up 2.2%</h2>
<div class="lb-trans"><h2>史赛克股票上涨 2.2%</h2>
</div><p>SYK stock opened at $368.35 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. The stock has a market capitalization of $140.87 billion, a price-to-earnings ratio of 48.79, a PEG ratio of 2.66 and a beta of 0.94. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The business's fifty day moving average price is $369.38 and its two-hundred day moving average price is $380.68.</p>
<div class="lb-trans"><p>SYK 股票在周五开盘价为 368.35 美元。该公司的债务与股本比率为 0.70，流动比率为 1.78，速动比率为 1.06。该股票的市值为 1,408.7 亿美元，市盈率为 48.79，PEG 比率为 2.66，贝塔值为 0.94。史赛克公司的 52 周最低价为 329.16 美元，52 周最高价为 406.19 美元。该公司的 50 日移动平均价格为 369.38 美元，200 日移动平均价格为 380.68 美元。</p>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一生，请考虑这些</li>
</ul>
</div><p>Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, topping analysts' consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company had revenue of $6.06 billion for the quarter, compared to analysts' expectations of $6.04 billion. During the same quarter last year, the business earned $2.87 earnings per share. Stryker's revenue was up 10.2% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, equities analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>史赛克（NYSE:SYK - 获取免费报告）最近在 10 月 30 日（星期四）发布了季度财报。该医疗科技公司报告季度每股收益为 3.19 美元，超出分析师一致预期的 3.13 美元，超出幅度为 0.06 美元。史赛克的股本回报率为 23.94%，净利润率为 12.25%。该公司季度收入为 60.6 亿美元，而分析师预期为 60.4 亿美元。去年同期，该公司每股收益为 2.87 美元。史赛克的收入同比增长 10.2%。史赛克已将其 2025 财年的指导目标设定为每股收益 13.500-13.600 美元。平均而言，股票分析师预计史赛克公司今年将发布每股收益 13.47 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of brokerages have recently weighed in on SYK. Wells Fargo &amp; Company lifted their price target on Stryker from $452.00 to $456.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, November 14th. Sanford C. Bernstein reiterated an &#34;outperform&#34; rating on shares of Stryker in a research note on Monday, November 3rd. Truist Financial boosted their price target on Stryker from $392.00 to $400.00 and gave the company a &#34;hold&#34; rating in a research note on Friday, November 14th. Barclays raised their price objective on shares of Stryker from $443.00 to $453.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, October 22nd. Finally, Rothschild &amp; Co Redburn began coverage on shares of Stryker in a research note on Thursday, September 18th. They set a &#34;neutral&#34; rating and a $420.00 price target for the company. Thirteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $434.37.</p>
<div class="lb-trans"><p>一些券商最近对 SYK 发表了看法。富国银行将史赛克的目标价从 452.00 美元上调至 456.00 美元，并在 11 月 14 日的报告中给予该公司 “增持” 评级。桑福德·C·伯恩斯坦在 11 月 3 日的研究报告中重申了对史赛克股票的 “跑赢大盘” 评级。Truist Financial 在 11 月 14 日的研究报告中将史赛克的目标价从 392.00 美元上调至 400.00 美元，并给予该公司 “持有” 评级。巴克莱在 10 月 22 日的研究报告中将史赛克的目标价从 443.00 美元上调至 453.00 美元，并给予该公司 “增持” 评级。最后，罗斯柴尔德与红烧开始覆盖史赛克股票，并在 9 月 18 日的研究报告中设定了 “中性” 评级和 420.00 美元的目标价。十三位研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 434.37 美元。</p>
</div><ul>
<li>3 Stocks Helping to Bring AI to Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
</div><p><strong>Get Our Latest Analysis on Stryker</strong></p>
<div class="lb-trans"><p><strong>获取我们对史赛克的最新分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other Stryker news, insider Viju Menon sold 500 shares of the company's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the sale, the insider owned 12,511 shares in the company, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Preston Wendell Wells sold 165 shares of the company's stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the sale, the chief financial officer directly owned 6,694 shares in the company, valued at $2,449,200.72. This trade represents a 2.41% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 522,618 shares of company stock valued at $185,577,237. Company insiders own 5.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他史赛克新闻中，内部人士 Viju Menon 在 8 月 25 日（星期一）出售了 500 股公司的股票。该股票以平均价格 390.61 美元出售，总价值为 195,305.00 美元。出售后，内部人士持有该公司 12,511 股，价值约为 4,886,921.71 美元。此次交易使其持仓减少了 3.84%。该交易在 SEC 的文件中披露，相关信息可通过此链接访问。此外，首席财务官 Preston Wendell Wells 在 11 月 20 日（星期四）出售了 165 股公司的股票。这些股票以平均价格 365.88 美元出售，总交易额为 60,370.20 美元。出售后，首席财务官直接持有该公司 6,694 股，价值为 2,449,200.72 美元。此次交易使其持仓减少了 2.41%。该出售的 SEC 文件提供了更多信息。在过去三个月中，内部人士已出售 522,618 股公司股票，价值为 185,577,237 美元。公司内部人士持有公司 5.90% 的股票。</p>
</div><h2>Stryker Company Profile</h2>
<div class="lb-trans"><h2>史赛克公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>史赛克公司是一家医疗科技公司。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换手术的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>How to Short a Stock in 5 Easy Steps</li>
<li>A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves</li>
<li>Most active stocks: Dollar volume vs share volume</li>
<li>12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming</li>
<li>Using the MarketBeat Stock Split Calculator</li>
<li>Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比史赛克更好</li>
<li>如何在 5 个简单步骤中做空股票</li>
<li>一项宏伟的人工智能投资？斯坦利·德鲁肯米勒最新的科技动态</li>
<li>最活跃的股票：美元交易量与股票交易量</li>
<li>12 位分析师刚刚上调了 CrowdStrike 的目标——他们预见了什么</li>
<li>使用 MarketBeat 股票拆分计算器</li>
<li>帕洛阿尔托网络的股票刚刚回调——这是一个理想的买入区吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Artisan 合伙有限合伙公司减少了其在史赛克公司 $SYK 的持仓